CE heads into today's earnings release with short sellers holding meaningful positions and a string of analyst target cuts framing the debate.
Short interest has built quietly but consistently. Bears hold roughly 7.6% of the free float — a level that has crept 5% higher over the past month, with another 3% added in the past week alone. A brief spike on July 28 saw shares short jump to over 11 million before partially reversing, suggesting some tactical positioning around the print rather than a sustained new wave. Borrowing remains cheap at 0.45%, down from over 0.5% a month ago, and availability is ample at around ten times current short interest — so there is no mechanical squeeze pressure in the lending market. Options positioning is similarly calm: the put/call ratio of 0.97 is almost exactly in line with its 20-day average, showing no unusual demand for downside protection.
The real tension is in the analyst community, where the direction of travel has been one-way. Morgan Stanley cut its target from $72 to $58 in mid-July while holding an Equal-Weight rating. BMO Capital dropped from $80 to $57 in early July. Mizuho trimmed to $55, and Bank of America — one of the stock's more constructive voices — lowered to $63 while keeping a Buy. The consensus mean target of $67.50 implies roughly 50% upside to the current $45.24 price, but that gap reflects how far the stock has fallen, not renewed conviction. The stock is down 5% over the past month despite a 4% bounce this week, and the valuation picture is bleak: price-to-book has slipped to 0.98 and the P/E sits below 7.2. Bulls point to a potential macro recovery in automotive and electronics as the key catalyst that could push EBITDA back toward $2.5 billion. Bears point to acetyl demand running at two-decade lows in key Western Hemisphere markets, persistent weakness in European and Chinese auto end-markets, and a debt load that leaves little margin for error.
Past prints have punished disappointments severely. The May 2026 report sent the stock down 15% on the day and a further 13% over the following five days. The February print produced an 8% one-day drop and a similar five-day decline. That pattern puts pressure on today's release to deliver something better than the market's cautious setup implies.
The print will test whether Celanese can show any stabilization in acetyl volumes and enough debt management progress to restore confidence in the earnings recovery thesis.
See the live data behind this article on ORTEX.
Open CE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
